Member Info for Cashintime

The Delaware court holding a final hearing this Friday 14th. I wonder will there be a ruling the same day or at a later date. It is only guesswork on our part that this minor legal issue is what is causing the stumbling block for the completion of the deal with HOOKIPA.

They could be going for a buy out as they have an avenue now to getting over 30% if they also go for some of the $30m subscription.

Hi Spuddy, Gilead have already an option on purchasing $8.75 m worth of extra shares following their last buy in. If they go over 30% they will have to make an offer. I am sure that they have their own maths done and will decide how and when they take over this company on the cheap or pay milestone payments.

There will be a sell off here as at the moment it is better to hold HOOKIPA share for the special dividend. It puts us at an unfair disadvantage.

The H900 is seemingly our new flagship product and I think it was Dave Almonds choice of out of temporary favour blockbuster product with massive potential, dropped by Roche only due to a change of direction.

I think Gilead are putting first dips on Polb 001 and placing it on the back burner for a couple of years or whenever it suits them.

We were all waiting for a deal announcement that will blow the lid off and this dilution is a bitter pill to swallow after 3 years of holding. We need to 3 bags first just to get back to IPO. I don't think this raise will be done @ $ 2.81 as that was an indicative 60 day example only. CF didn't clarify that in the video today or any of our concerns really.

Why didn't they announce the cut off date for CVRs as simultaneous with the Jan 2nd RNS. That way only existing HOOKIPA shareholders would profit. Nobody will want Poolbeg share pre merger unless they get them at a steal. What else did CF think was going to happen.

I would like to know will those who participate in the fundraise be eligible for the CVR percentages because if they are it has to be classed as a scam.

I am furious that my shares have halved in value over this arrangement. I think the shareprice may well recover once the reverse is in place but we have for the moment been subjected to this equity reduction with more pain to come following the raise.

Doubtless CF will give himself and his crew some millions in share options but we as shareholders don't have that luxury.

The big boys are taking over our asset on the cheap .CF will now be Gilead's puppet on a string.

Eventually there will be a cut off date for the present HOOK shareholders that will benefit from any milestone payments.

Why should anybody buy HOOK shares after this time if they don't be on a level playing pitch with other stakeholders.

It's like 2 people working at the same job with different rates of pay, pension benefits etc.

It happens but is never good.

I would like to see the terms of the CVR arrangement changed in fact abolished altogether as it is damaging our current shareprice and it makes HOOK shares more attractive to buy than ours.

I am just after a detailed read once more of this morning's RNS and the major thing I can see is in the needed clarity of the CRV arrangement for H200 and H500, the two products that Gilead has partnered up with.

It's understandable that HOOKs shareholders would like to profit more than us with any potential milestone payments for these products but a real partnership should be willing to share at the 55/45 % ratio. It complicates things and most importantly prioritises the attraction of HOOK v POLB shares for this upside before a cut off date is announced for this CRV. I think this will hold us back a bit from our shareprice following HOOKs by the 0.03 per share ratio.

Surely that date could have been made as today the date of this announcement.

One other major point is an offer for POLB by a third party invalides this HOOK deal so it just may force a deal to be made by a third party who has been standing on the sidelines.

It will now force their hand to be played as we were said to have had 2 parties interested. If this is a fact they will now have to come to the table with an offer or alternative arrangement. We will see.

Now premarket moving near 30%. Looking good and puts us up above 6p.

At the moment the premarket value of Hook is up nearly 20%. This should currently see us @ 5.7p here and rising.

This deal was probably arranged in November when the HOOK shareprice was around $3. The 0.03 share for every Poolbeg share would make more sense then as it would have maintained our shareprice.

It is unfortunate that it has dropped lately as it hits us hard this morning. The American analysts could view this merger positively and this will immediately move us up as we are now joined at the hip.

We were going nowhere on AIM and now can have access to the American deep pockets.

This shareprice can lift this afternoon when the American market do their research on us.

Together we will be seen as as a stronger entity.

The way it appears now is that we are linked to 0.03 of whatever HOOK shareprice is. As their shareprice moves we are inversely proportional to it by this factor. When American market opens at 2.30 the market will have it's say.

Looking like the market wants to bring us down to about 4.8p after the 0.03 Hook share for every Poolbeg one and from cents to pence x.8 for dollar to sterling.

Gilead have being buying in to HOOK recently so we are in bed with them now. We will be part of a bigger entity soon enough and the market will speak soon.

We have hooked our Nasdaq "falling angel".

G

Gilead on board and our route to Nasdaq. Alot of reading but looks good to me. Looking forward to a bit of company PR later but especially the opening price when those wiser will give their approval. GLALTHs.

By Hook or by crock we will get there.

Major news this morning. The market will have it's say very shortly.

It's looking like we will get no Christmas presents here but time still. An end of year carrot would even be nice . Even Rudolph would get that. We live in hope for a transformational 2025.

Let's hope 2025 will be our year. We have all money tied up for years here and our pivoting to cash generation in 2024 ,deals,Nasdaq hasn't happened. I have no doubt a deal is being finalised. Shareprice is finishing the year badly so far. Some day we will wake up to the red dot we have been waiting for

I wouldn't worry too much about all of this as things are said to be going well. A deal like this can take time and I would say is fairly complex to complete. When it does land it will give us plenty to look forward to in the future.

CF has to give a bit of clarity so we are all playing on a level pitch.

Session Name: 703. Cellular Immunotherapies other than CAR-T Cells: Basic and Translational: Poster I

Session Date and Time: Saturday, 7 December 2024, 5:30 PM - 7:30 PM PST